Capital Impact Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,598	Closed	-$469K	–	161
2023 Q2	$469K	Hold	15,598	–	–	0.52%	96
2023 Q1	$565K	Sell	15,598 -6,692	-30%	-$242K	0.69%	58
2022 Q4	$795K	Hold	22,290	–	–	0.78%	30
2022 Q3	$760K	Sell	22,290 -232	-1%	-$7.91K	0.76%	35
2022 Q2	$651K	Sell	22,522 -3,388	-13%	-$97.9K	0.6%	57
2022 Q1	$837K	Buy	+25,910	New	+$837K	0.61%	63
2021 Q4	–	Sell	-48,500	Closed	-$1.29M	–	141
2021 Q3	$1.29M	Hold	48,500	–	–	0.51%	83
2021 Q2	$1.49M	Hold	48,500	–	–	0.48%	85
2021 Q1	$1.27M	Buy	+48,500	New	+$1.27M	0.44%	80
2020 Q4	–	Sell	-83,632	Closed	-$1.74M	–	120
2020 Q3	$1.74M	Hold	83,632	–	–	0.52%	86
2020 Q2	$1.99M	Hold	83,632	–	–	0.66%	73
2020 Q1	$1.51M	Buy	83,632 +5,001	+6%	+$90K	0.63%	77
2019 Q4	$1.87M	Buy	78,631 +2,866	+4%	+$68K	0.66%	88
2019 Q3	$2.08M	Buy	75,765 +12,846	+20%	+$353K	0.79%	48
2019 Q2	$2.02M	Buy	62,919 +18,254	+41%	+$585K	0.74%	51
2019 Q1	$1.45M	Hold	44,665	–	–	0.64%	89
2018 Q4	$1.45M	Buy	44,665 +3,661	+9%	+$118K	0.62%	92
2018 Q3	$2.05M	Buy	41,004 +3,239	+9%	+$162K	0.7%	59
2018 Q2	$2.2M	Sell	37,765 -5,260	-12%	-$307K	0.82%	35
2018 Q1	$1.97M	Buy	43,025 +13,845	+47%	+$634K	0.81%	40
2017 Q4	$1.16M	Hold	29,180	–	–	0.5%	110
2017 Q3	$1.17M	Hold	29,180	–	–	0.52%	118
2017 Q2	$1.26M	Sell	29,180 -11,179	-28%	-$482K	0.57%	81
2017 Q1	$1.26M	Buy	+40,359	New	+$1.26M	0.5%	110
2015 Q1	–	Sell	-16,796	Closed	-$139K	–	295
2014 Q4	$139K	Hold	16,796	–	–	0.07%	183
2014 Q3	$146	Hold	16,796	–	–	﹤0.01%	150
2014 Q2	$184K	Buy	+16,796	New	+$184K	0.14%	99